Objectives: To investigate the link between two NDM-1-positive Acinetobacter isolates from the same hospital, the plasmid profiles of the isolates were examined. These two isolates were found from a surveillance programme within 3 months from two patients without obvious physical contact or hospitalization time overlap.
Introduction
Hospital-acquired infection involving MDR bacteria is an emerging health problem worldwide. Among these bacteria, Acinetobacter species can cause urinary tract and wound infections, pneumonia and bacteraemia with high morbidity and mortality. 1 More than 30 genomic species have been identified in this genus, and, in the clinical setting, the most prevalent species is Acinetobacter baumannii. Some Acinetobacter species, which cannot be differentiated from A. baumannii using conventional phenotypic tests, are reported as the Acinetobacter calcoaceticus-A. baumannii (Acb) complex. 2 These bacteria gained attention in the past decade because of their increasing incidence as clinical isolates that have accumulated resistance to many commonly used antibiotics, including the last-line carbapenem agents. Since 2008, a new b-lactamase, NDM-1 (New Delhi metallob-lactamase 1), has spread rapidly worldwide to many species of Gram-negative bacteria. 4 Several NDM-1-positive Acinetobacter species, including A. baumannii, Acinetobacter lwoffii and Acinetobacter pittii, have been reported in China and the bla NDM-1 genes located on the plasmids have exhibited nearly identical sequences. 5 -7 In contrast, A. baumannii isolates from Europe have been shown to have chromosomal integration of a composite transposon with two copies of ISAba125 flanking the bla NDM-1 gene and its downstream sequences. 8 We previously identified a bla NDM-1 -positive isolate, M131, from the Taiwan Surveillance of Antimicrobial Resistance programme. Subsequent investigation identified the isolate to be Acinetobacter soli. 9 In the process of a follow-up epidemiological investigation to trace the source of M131, another bla NDM-1 -positive isolate (MS32) from a different patient was discovered. MS32 belonged to another species. The two patients had neither physical contact nor hospitalization overlap. Therefore, we investigated the link between these isolates to determine the possibility of bla NDM-1 transfer between different Acinetobacter species. Table S1 (available as Supplementary data at JAC Online) lists the bacterial isolates used in this study. Bacterial isolates were initially selected after growth on MacConkey agar plates that contained imipenem (1 mg/L) and were then tested for the presence of carbapenemases using the modified Hodge test. 10 Bacteria that tested positive in the modified Hodge test were analysed for the presence of bla NDM-1 using PCR (NDM1F: 5 ′ -CGCCTCTGTCACATCGAAAT; NDM1R: 5 ′ -CATTAGCCGCTGCATTGAT). The MICs of various antimicrobial agents were determined by broth microdilution following the CLSI guidelines, 10 and using Etest (bioMé rieux, Marcy-l'Étoile, France) following the manufacturer instructions.
Materials and methods

Bacterial isolation and antimicrobial susceptibility tests
DNA sequencing, de novo assembly and annotation
Complete plasmid sequencing of A. soli M131 and A. pittii MS32 was performed using the 454 pyrosequencing technology and the Illumina MiSeq platform. In addition, genomic DNA samples of M131 and MS32 were sequenced to estimate the copy number of plasmids. All assembled plasmid sequences were deposited into the National Center for Biotechnology Information GenBank. The accession numbers are JX072963 (pM131_NDM1), JX101638 -JX101647 (pM131-11 -pM131-2), KJ616405 (pMS32-1) and KJ616406 (pMS32-3).
Conjugation
Spontaneous rifampicin-resistant mutants of the seven Acinetobacter species (A. baumannii, A. pittii, Acinetobacter nosocomialis, A. calcoaceticus, A. lwoffii, Acinetobacter junii and A. soli) from stationary cultures were selected as the plasmid recipients. The donor strain, A. pittii MS32, and each recipient were mixed in a ratio of 2: 1 and were harvested by centrifugation, which was followed by spotting onto LB agar at 288C for 16 h. The mated cells were then resuspended in 5 mL of LB broth and plated onto selective and non-selective LB agar. After overnight incubation at 378C, the grown colonies were counted to calculate the conjugation frequency. LB agar containing both 2 mg/L imipenem and 25 mg/L rifampicin was used to select the Acinetobacter transconjugants.
Results and discussion
Case history
A bla NDM-1 -positive Acinetobacter isolate (M131) was detected from a national surveillance programme. 9 Investigation into the origin of M131 was conducted by the CDC, Ministry of Health and Welfare, Taiwan. All carbapenem-resistant Acb complex saved by the hospital during the 3 months prior to and after the date of M131 isolation was screened for the bla NDM-1 gene. Another bla NDM-1 -positive Acinetobacter isolate (MS32) was found from a different patient who was discharged 10 days before the M131 patient was admitted to the hospital. Both patients stayed in the same ICU. Both M131 and MS32 were initially reported as members of the Acb complex on the basis of their biochemical reactions. However, subsequent genotyping studies determined that M131 was A. soli 9 and MS32 was A. pittii. The two isolates were resistant to doripenem, imipenem and meropenem (MIC .32 mg/L), but their susceptibilities to ciprofloxacin, gentamicin and trimethoprim/sulfamethoxazole differed (Table S2 ). In vitro conjugation experiments showed that carbapenem and amikacin resistance could be transferred to their Escherichia coli transconjugants. Since these two patients did not have an international travel history, this prompted us to investigate the genetic features of these NDM-1-positive Acinetobacter isolates using WGS.
NDM-1-positive plasmids from M131 and MS32 are identical
The plasmid DNA samples of M131 and MS32 were subjected individually to shotgun sequencing. Isolate M131 contained 11 distinct plasmids ranging in size from 1735 to 84 994 bp, whereas MS32 contained three plasmids with sizes of 11 465, 47 271 and 94 418 bp (Table S3 ). The plasmids of the two isolates were different except for the NDM-1-positive plasmids, pM131_NDM1 (47 271 bp) and pMS32-2 (47 271 bp), which were identical at the nucleotide level. In silico analysis of plasmid replicon types for A. baumannii 11 revealed that seven of the 11 plasmids from M131 could be classified into five homology groups on the basis of the similarity between annotated plasmid replicase and references at the protein level (Table S3 ). The copy numbers of the bla NDM-1 -containing plasmids in these two Acinetobacter hosts were similar (3.1 in M131 and 3.7 in MS32).
Comparison between pM131_NDM1 and other NDM-1-positive plasmids from Acinetobacter species Because these two NDM-1-positive plasmids (pM131_NDM1 and pMS32-2) were identical, hereafter we refer to the plasmid as pM131_NDM1 in this report. This 47.2 kb plasmid did not contain any replicase sequence similar to those of the known replicon types. A 14 kb operon (nucleotide position 31 314 -45 591), which included 12 genes of a Ti-like type IV secretion system (T4SS), was indicative of its plasmid transfer function (Figure 1) . Two antimicrobial resistance genes, aphA6 and bla NDM-1 , were recognized in pM131_NDM1, conferring resistance to amikacin and carbapenem, respectively.
A NDM-1-positive plasmid in Acinetobacter species 2735 
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Plasmids containing the bla NDM-1 sequence have been reported in many countries, and these NDM-1-positive bacteria included those belonging to Enterobacteriaceae, Pseudomonas aeruginosa and various Acinetobacter species. 5,6,12 -16 Seven completely sequenced NDM-1-positive plasmids from different Acinetobacter species have been published. 5 -7,14 -16 The pNDM-BJ01 (India) plasmid was isolated from India, whereas the other six plasmids were all isolated from China. Plasmid pAP_D499 was originally reported in 2008 to be an A. pittii isolate from the ICU of a hospital in Beijing. Notably, retrospective analysis can trace pNDM-BJ01 (India) back to an Indian isolate originally identified in 2005. Comparative analysis between pM131_NDM1 and the seven published plasmids revealed that all of these NDM-1-positive plasmids isolated from Acinetobacter species were conserved in overall structure. The sequence identity was not only in the bla NDM-1 gene region but also present throughout the entire 6 pNDM-BJ01 (China, JQ001791) and pNDM-BJ02 (JQ060896), 5 pAbNDM-1 (JN377410), 14 pNDM-AB (KC503911) 7 and pNDM-BJ01 (India, KF702385). 16 The thick black line indicates the sequence identity, and divergences are highlighted. The grey dot denotes a single nucleotide substitution. The white arrows mark the predicted ORFs and blue arrows indicate genes functioning in the type IV secretion system. Boxes filled with different colours indicate different IS elements. Black triangles indicate the inverted perfect repeats. The plasmids of these transconjugants were extracted and the structure of the transferred plasmid was confirmed using restriction analysis. c Imipenem and sodium azide were used to select transconjugants when E. coli J53 was the recipient.
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plasmid backbone. Based on the sequence of the bla NDM-1 gene region, pAP_D499 was the closest relative to pM131_NDM1 because both contained similar structures, with the bla NDM-1 gene region bracketed by two inverted IS elements, ISAba125 and ISAba11 (Figure 1 ).
Conjugal transfer ability of the NDM-1 plasmid among Acinetobacter species
Considering the findings that the 47 kb plasmid is structurally conserved and contains a type IV secretion system, we reasoned that whole-plasmid transfer through conjugation might have accounted for the detected clinical incidence of M131 and MS32 in Taiwan, and the presence of similar plasmids throughout Asia ( Figure S1 ). Therefore, we performed conjugation experiments using MS32 as a donor. Seven Acinetobacter species including members of the Acb complex (five strains representing four species), two other Acinetobacter species, namely A. junii and A. lwoffii, and an emerging species, A. soli, 17 were used as recipients to test the conjugal transfer ability of this 47 kb plasmid. As shown in Table 1 , the frequencies of the conjugation transfer of the plasmid into these Acinetobacter species were diverse, ranging from 10 21 to 10 28 . The successful transfer of this 47 kb plasmid into those transconjugants was analysed through restriction enzyme digestion with PmeI and XbaI (data not shown). The conjugal transfer ability of pMS32-2 into three clinically prominent species from the Acb complex (A. baumannii, A. pittii and A. nosocomialis) is substantially lower than that of other species less commonly associated with human disease, such as A. junii, A. calcoaceticus and A. soli. This suggests that the non-pathogenic Acinetobacter species could acquire this plasmid relatively easily and might serve as a reservoir for the NDM-1-positive plasmid in the environment.
Conclusions
Our study identified a 47 kb NDM-1-positive plasmid in two Acinetobacter isolates within 3 months in the same hospital. The high level of sequence identity among NDM-1-positive plasmids isolated from Acinetobacter spp. in Asia, based on the current investigation and previous studies, 5, 6 indicates that the effective transfer and rapid dissemination of this 47 kb plasmid have occurred within the Acinetobacter genus ( Figure S1 ). Despite the low in vitro conjugation efficiency of this plasmid into A. baumannii and A. nosocomialis, the two species with the highest prevalence in the clinical setting, the adaptation and conservation of this plasmid in other Acinetobacter spp., namely A. pittii and A. soli, are likely a potential threat to infection control. The two MDR strains in the present study were discovered in a surveillance programme targeting antimicrobial resistant bacteria and by subsequently investigating bacterial isolates deposited by the hospital. Because detecting drug-resistant genes and identifying their origins are crucial to halting the dissemination of MDR bacteria, we recommend that WGS be implemented as part of antimicrobial resistance surveillance programmes.
